ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

VAR Varian Medical System

177.07
0.00 (0.00%)
Pre Market
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Varian Medical System NYSE:VAR NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 177.07 0 01:00:00

Current Report Filing (8-k)

26/04/2017 10:11pm

Edgar (US Regulatory)


  

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

___________

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934 

 

Date of report (Date of earliest event reported) April 26, 2017

  

VARIAN MEDICAL SYSTEMS, INC.
(Exact Name of Registrant as Specified in its Charter)

  

Delaware 1-7598 94-2359345
(State or Other Jurisdiction
of Incorporation)
(Commission File
Number)
(IRS Employer
 Identification No.)

 

3100 Hansen Way, Palo Alto, CA 94304-1030
(Address of Principal Executive Offices) (Zip Code)

 

Registrant's telephone number, including area code (650) 493-4000

 

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

  

 

 

 

Item 2.02. Results of Operations and Financial Condition .

 

On April 26, 2017, Varian Medical Systems, Inc. announced that: “Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2017.” A copy of the press release is attached as Exhibit 99.1 and incorporated by reference into this item.

 

Item 9.01. Financial Statements and Exhibits .

 

(d) Exhibits .

 

99.1 Press Release dated April 26, 2017 entitled “Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2017.”

 

 

  2  

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

  Varian Medical Systems, Inc.
     
     
  By: /s/ John W. Kuo
  Name:  John W. Kuo
  Title: Senior Vice President, General Counsel and Corporate Secretary

  

Dated: April 26, 2017

 

 

 

  3  

 

 

EXHIBIT INDEX

 

 

 

Number

Exhibit

 

99.1 Press Release dated April 26, 2017 entitled “Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2017.”

 

 

 

 

 

1 Year Varian Medical System Chart

1 Year Varian Medical System Chart

1 Month Varian Medical System Chart

1 Month Varian Medical System Chart

Your Recent History

Delayed Upgrade Clock